Santa Cruz Biotechnology now offers a broad range of ST Inhibitors. Sodium-dependent serotonin transporter (ST) functions as a regulator of serotonergic signaling via transport of serotonin molecules from the synaptic cleft back into the pre-synaptic terminal for re-utilization. ST plays a key role in mediating regulation of the availability of serotonin to other receptors of serotonergic systems. ST Inhibitors offered by Santa Cruz inhibit ST and, in some cases, other neurotransmitter and serotonergic related proteins. View detailed ST Inhibitor specifications, including ST Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
Items 11 to 20 of 33 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Vandetanib | 443913-73-3 | sc-220364 sc-220364A | 5 mg 50 mg | $167.00 $1353.00 | ||
Vandetanib, a VEGFR inhibitor, disrupts VEGF signaling pathways. By inhibiting VEGFR, it may indirectly influence ST, potentially modulating cellular processes associated with ST function and VEGF-related signaling cascades. | ||||||
Clomipramine hydrochloride | 17321-77-6 | sc-203898 | 1 g | $38.00 | 2 | |
Clomipramine hydrochloride features a complex aromatic system that enhances its electrophilic character, making it a potent acid halide. The presence of a tertiary amine contributes to its ability to form hydrogen bonds, influencing its reactivity with nucleophiles. Its unique conformational flexibility allows for diverse molecular interactions, while the chloride ion enhances its solubility in various solvents. This interplay of structural elements significantly affects its kinetic behavior in chemical reactions. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib, a dual Src/Abl kinase inhibitor, affects Src signaling pathways. Its inhibition of Src can indirectly modulate ST, potentially altering cellular responses associated with ST function and Src-mediated signaling cascades. | ||||||
Sertraline hydrochloride | 79559-97-0 | sc-201104 sc-201104A sc-201104B | 10 mg 50 mg 100 mg | $68.00 $104.00 $156.00 | 2 | |
Sertraline hydrochloride exhibits a distinctive structural framework characterized by a phenyl ring and a piperazine moiety, which contribute to its reactivity as an acid halide. The presence of a secondary amine facilitates the formation of stable complexes with nucleophiles, while the hydrochloride form enhances its ionic character, promoting solvation in polar environments. This unique combination of features influences its reaction kinetics, allowing for varied pathways in chemical transformations. | ||||||
Tomoxetine hydrochloride | 82248-59-7 | sc-204349 sc-204349A | 10 mg 50 mg | $161.00 $686.00 | ||
Tomoxetine hydrochloride features a unique aromatic structure that enhances its reactivity as an acid halide. The presence of a tertiary amine allows for selective electrophilic interactions, facilitating the formation of covalent bonds with nucleophiles. Its hydrochloride form increases solubility in aqueous solutions, promoting rapid diffusion and interaction with other chemical species. This behavior influences its kinetics, enabling diverse reaction pathways in synthetic applications. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib, a BCR-ABL and c-Kit inhibitor, disrupts BCR-ABL signaling. By inhibiting this pathway, it may indirectly impact ST, potentially modulating cellular processes associated with ST function and BCR-ABL-related signaling cascades. | ||||||
Venlafaxine Hydrochloride | 99300-78-4 | sc-201102 sc-201102A | 10 mg 50 mg | $138.00 $612.00 | 3 | |
Venlafaxine Hydrochloride exhibits a distinctive dual-ring structure that contributes to its reactivity as an acid halide. The presence of an ether linkage enhances its electrophilic character, allowing for efficient nucleophilic attack. Its hydrochloride form enhances ionic interactions, improving solubility in polar solvents and facilitating rapid reaction kinetics. This solubility promotes diverse pathways in chemical synthesis, enabling complex transformations and interactions with various reagents. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib, an EGFR inhibitor, targets EGFR signaling pathways. Its inhibition of EGFR can indirectly influence ST, potentially modulating cellular responses associated with ST function and EGFR-mediated signaling cascades. | ||||||
Duloxetine | 116539-59-4 | sc-279011 | 10 mg | $129.00 | 3 | |
Duloxetine features a unique bicyclic structure that enhances its reactivity profile as an acid halide. The presence of a nitrogen atom within the ring system contributes to its electrophilic nature, facilitating interactions with nucleophiles. Its ability to form stable adducts through hydrogen bonding allows for diverse reaction pathways. Additionally, the compound's moderate polarity aids in solvation, promoting efficient reaction kinetics and enabling a range of synthetic applications. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib, an EGFR inhibitor, disrupts EGFR signaling pathways. Its inhibition of EGFR can indirectly modulate ST, potentially altering cellular responses associated with ST function and EGFR-mediated signaling cascades. | ||||||